Literature DB >> 22503741

Design, synthesis and biological evaluation of novel chalcone derivatives as antitubulin agents.

Hui Zhang1, Jia-Jia Liu, Jian Sun, Xian-Hui Yang, Ting-Ting Zhao, Xiang Lu, Hai-Bin Gong, Hai-Liang Zhu.   

Abstract

A series of novel chalcone derivatives have been designed and synthesized, and their biological activities were also evaluated as potential inhibitors of tubulin. These compounds were assayed for growth-inhibitory activity against MCF-7 and A549 cell lines in vitro. Compound 3d showed the most potent antiproliferative activity against MCF-7 and A549 cell lines with IC(50) values of 0.03 and 0.95 μg/mL and exhibited the most potent tubulin inhibitory activity with IC(50) of 1.42 μg/mL. Docking simulation was performed to insert compound 3d into the crystal structure of tubulin at colchicines binding site to determine the probable binding model. Based on the preliminary results, compound 3d with potent inhibitory activity in tumor growth may be a potential anticancer agent.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503741     DOI: 10.1016/j.bmc.2012.03.055

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Synthesis and biological evaluation of structurally diverse α-conformationally restricted chalcones and related analogues.

Authors:  Casey J Maguire; Graham J Carlson; Jacob W Ford; Tracy E Strecker; Ernest Hamel; Mary Lynn Trawick; Kevin G Pinney
Journal:  Medchemcomm       Date:  2019-06-04       Impact factor: 3.597

Review 2.  Chalcone: A Privileged Structure in Medicinal Chemistry.

Authors:  Chunlin Zhuang; Wen Zhang; Chunquan Sheng; Wannian Zhang; Chengguo Xing; Zhenyuan Miao
Journal:  Chem Rev       Date:  2017-05-10       Impact factor: 60.622

3.  FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma.

Authors:  Yuanyuan Shi; Xuejiao Liu; Mangaladoss Fredimoses; Mengqiu Song; Hanyong Chen; Kangdong Liu; Mee-Hyun Lee; Zigang Dong
Journal:  J Cell Biochem       Date:  2017-10-27       Impact factor: 4.429

Review 4.  A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors.

Authors:  Wenjing Liu; Min He; Yongjun Li; Zhiyun Peng; Guangcheng Wang
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

5.  Synthesis and biological evaluation of halogenated phenoxychalcones and their corresponding pyrazolines as cytotoxic agents in human breast cancer.

Authors:  Peter A Halim; Rasha A Hassan; Khaled O Mohamed; Soha O Hassanin; Mona G Khalil; Amr M Abdou; Eman O Osman
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

6.  Novel chalcone-derived pyrazoles as potential therapeutic agents for the treatment of non-small cell lung cancer.

Authors:  Natalia Maciejewska; Mateusz Olszewski; Jakub Jurasz; Marcin Serocki; Maria Dzierzynska; Katarzyna Cekala; Ewa Wieczerzak; Maciej Baginski
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

7.  3-Bromo-2-hy-droxy-benzaldehyde.

Authors:  Jessica B Metlay; Joseph M Tanski
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-07-18

8.  Diverse Molecular Targets for Chalcones with Varied Bioactivities.

Authors:  Bo Zhou; Chengguo Xing
Journal:  Med Chem (Los Angeles)       Date:  2015-08-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.